2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
7
Uterine Cervical Dysplasia
6
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Squamous Intraepithelial Lesions
1
Precancerous Conditions
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Barrett Esophagus
1
Acquired Immunodeficiency Syndrome
1
Interventions
Biopsy
12
Peripheral Blood Stem Cell Transplantation
9
Cyclophosphamide
9
fludarabine phosphate
8
Whole-Body Irradiation
8
Polymerase Chain Reaction
7
Tacrolimus
6
Mycophenolic Acid
6
Gene Expression Profiling
6
Colposcopy
6
Busulfan
6
Microarray Analysis
5
Immunohistochemistry
5
Epoetin Alfa
5
Celecoxib
5
Aminolevulinic Acid
5
Sulindac
4
Selenium
4
Methotrexate
4
Melphalan
4
Cyclosporine
4
Cetuximab
4
Antilymphocyte Serum
4
Vaginal Smears
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Etoposide
3
Eflornithine
3
Darbepoetin alfa
3
Comparative Genomic Hybridization
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precancerous Conditions
×
Acetic Acid
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled